Adrian Snihur
About Adrian Snihur
Adrian Snihur serves as the Senior Director of Consulting at Shift Health, where he has worked since 2011. He holds advanced degrees in Neuroscience and has extensive experience in healthcare consulting across various global regions.
Work at Shift Health
Adrian Snihur has been serving as the Senior Director of Consulting at Shift Health since 2011. In this role, he provides strategic support to enhance research and commercialization activities for health-focused organizations. His work involves collaborating with clients from various sectors, including government, academia, industry, and the not-for-profit sector, to attract capital and facilitate partnerships. His extensive experience in consulting contributes to the development of convergent solutions in healthcare and life sciences.
Education and Expertise
Adrian Snihur holds a Ph.D. in Neuroscience from The University of Western Ontario, which he completed from 2005 to 2011. Prior to that, he earned a Master of Science in Neuroscience from Western University, studying from 2003 to 2005. His academic journey began with an Honours Bachelor of Science in Biology and Psychology from McMaster University, completed between 1999 and 2003. This educational background provides him with a strong foundation in both the scientific and business aspects of healthcare.
Background
Adrian Snihur has extensive experience working with public and private organizations across North America, Europe, Asia, and the Middle East. His diverse background includes leading projects in various disease areas, such as oncology, behavioral health, and HIV. This international exposure and multidisciplinary approach enable him to address complex challenges in the healthcare sector effectively.
Achievements
Adrian Snihur has presented research at numerous international scientific conferences, showcasing his contributions to the field. He is the first author on five original research papers published in renowned peer-reviewed academic journals. These publications reflect his commitment to advancing knowledge in neuroscience and healthcare, reinforcing his role as a thought leader in the industry.